A newly discovered blog post about gender transition procedures and hormone therapies for minors resulted in a vote by the ...
The FDA is removing any mention of risks related to breast cancer, heart disease, and dementia on hormone therapy products ...
Protesters opposing bills that would limit transgender kids’ access to puberty blockers and hormone therapies rally at the Texas Capitol on March 1. Credit: Lauren Witte/The Texas Tribune Nearly ...
Since the early 2000s, the FDA required a “black box” warning on products that use estrogen, progesterone, or both to treat ...
On November 10, the Food and Drug Administration announced it will remove the black box warning applied to estrogen-containing products since 2002. As the head of the FDA declared, “After 23 years of ...
For most women, menopause occurs naturally around the age of 49. In the lead up to menopause, the quality and quantity of ...
This article was reviewed by Julia Switzer, MD, FACOG. Menopause Belly Fat: Causes & Solutions Key takeaways Hormonal changes ...
“Transition-related care” is an umbrella term referring to a range of social practices, hormone therapies, mental health treatments and medical procedures that support a person’s gender identity.